Abstract:Background: It has become increasingly clear that γδ T cells are important components in both innate and adaptive immune systems, yet the cellular requirement for the activation of γδ T cells is still poorly defined. Like αβ T cells, human Vγ9Vδ2 T cells may be divided into four subsets: naive, central memory, effector memory and terminal differentiated cells, according to their surface expression of CD45RA and CD27. Whether human Vγ9Vδ2 T cells have functionally different subsets in response to influenza A (fluA) viruses remains unknown. Methods: Here we applied fluA virus-infected primary human monocyte-derived macrophages (MDMs) for examining the antiviral activity of phosphoantigen isopentenyl pyrophosphate (IPP)-expanded human Vγ9Vδ2 cells against influenza viruses. Different γδ T subsets were sorted with FACS Aria-II dependent on the surface expression levels of CD27 or CD56. Flow cytometry was used for phenotyping, cytotoxic assay and cytokine quantification. Specific blocking antibodies were utilized to uncover the mechanisms for γδ-T-mediated cytolytic antiviral effects. Results: In this study, we demonstrated that both central (CD45RA-CD27+) and effector (CD45RA-CD27-) memory Vγ9Vδ2 T had similar levels of immediate IFN-γ and cytotoxic responses to human and avian fluA virus-infected cells. In contrast, CD56+ Vγ9Vδ2 T cells had significantly higher cytotoxicity against fluA virus-infected cells, compared with CD56- counterparts, while both subsets had similar IFN-γ responses. We further demonstrated that the CD16-dependant degranulation pathway, but not antibodydependent cell-mediated cytotoxicity (ADCC), contributed to the superior cytotoxicity of CD56+ Vγ9Vδ2 T cells. Conclusion: Our study provides further evidence for the phenotypic and functional characterization of human Vγ9Vδ2 T subsets during fluA virus infection, and may help improve the γδ T cell-based immunotherapy for viral infection. As γδ T cell-based immunotherapy has been showed a great potential for treating fluA infection, our findings may help improve its efficacy for the control of viral infection.

The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity

Facilitating broad antibody responses

Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection

Maturation of germinal center B cells after influenza virus vaccination in humans

The IFN‐inducible GTPase IRGB10 Regulates Viral Replication and Inflammasome Activation During Influenza A Virus Infection in Mice

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection

Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells

Role of T Cell Help and Endoplasmic Reticulum Targeting in Protective CTL Response Against Influenza Virus

Clonally expanded IgG antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections

Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses

B cell alpha(v) integrin regulates germinal center derived lung-resident IgA B cell responses following influenza virus infection

CD4+ Follicular Regulatory T Cells Optimize the Influenza Virus-Specific B Cell Response.

mRNA-based influenza vaccine expands breadth of B cell response in humans

Phenotypic and Functional Characterization of Human Γδ T Cell Subsets in Response to Influenza A Viruses

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

Enhanced Influenza Immunity by Nasal Mucosal Administration of the TPGS-Modified Liposomal Vaccine

Germinal centers are permissive to subdominant antibody responses

Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway

Molecular basis for potent B cell responses to antigen displayed on particles of viral size

Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells